The latest pharmaceutical mergers and acquisitions news.
Nuclear medicine company Curium Pharma has acquired Monrol (Eczacıbaşı-Monrol Nuclear Products) to expand its presence in the sector.
Two biotech firms and a radiochemistry company will develop next-generation targeted alpha-therapies to treat various forms of cancer.
Global temperature-sensitive packing and digital solutions provider Cold Chain Technologies (CCT) has acquired Australia's Global Cold Chain Solutions (GCCS) to expand its Asia Pacific presence and capabilities.
Belgium biotechnology company Galapagos has made changes at the top as it prepares to split into two separate entities.
Finnish health and social care provider Mehiläinen has agreed to acquire Eastern European healthcare companies Regina Maria and MediGroup.
Business and technology consultancy HERAX Life Science has been acquired by ProductLife Group (PLG).
Northern Irish biostatistics and data science company, Exploristics, has announced that it has been acquired by MMS.
3M spin-off Solventum has announced that global supplier of analytical instruments Thermo Fisher Scientific has agreed to purchase its purification and filtration businesses unit for $4.1bn.
A division of European specialty generics platform Stragen Group, Stragen Services, has been acquired by ProductLife Group (PLG), a global consulting services specialising in areas around scientific, regulatory, compliance and digital transformation.
CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in vitro diagnostics (IVD). This will support the vision from Medix Biochemica to become the first-in-choice partner for raw materials in the IVD industry.
Subsidiary of Molex, Phillips Medisize, has announced the successful acquisition of Vectura Group Ltd. The acquisition was completed through an affiliate.
Infrareal holding has announced that it has entered into a corresponding transfer agreement with Takeda to acquire the 24-hectare site in Orth, Lower Austria – subject to merger control approval from Austrian regulators.